Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Latest keratitis Stories

88429946b57277552c51713e879606f0
2009-06-01 07:20:00

When contact lens maker Bausch & Lomb Inc. went private in 2007, it was not without good cause. Company leaders have explained that the company wanted to handle a disastrous recall of its popular lens cleaner "without a lot of outside distraction." In the past year, the optical products company has managed to quietly settle almost 600 lawsuits involving claims of fungal-infections, while dozens of individual claims are still waiting to be heard. In all, Bausch & Lomb Inc. has doled...

2009-04-10 12:36:00

New Contact Lens and Case Timer Solves Widespread Problem ST. LOUIS, April 10 /PRNewswire/ -- There are over 38 million contact lens wearers in the U.S. and children are the fastest growing segment. The contact lens industry is enjoying great success, but there is danger growing under those lenses. Danger in the form of hard to pronounce words like fusarium keratitis and acanthamoeba keratitis. These are nasty words that are causing eye health complications from minor eye infections to...

2009-01-26 14:44:00

Optometrists and other experts sponsor workshop to investigate increase in Acanthamoeba keratitis and to develop new testing methods to improve contact lens care products and protect against infections ST. LOUIS, Jan. 26 /PRNewswire/ -- In an effort to increase the safety and effectiveness of contact lenses and lens care products for consumers, doctors of optometry from the American Optometric Association (AOA) co-sponsored a workshop last week with the U.S. Food and Drug Administration's...

2009-01-26 10:02:00

TAMPA, Fla., Jan. 26 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, today announced that its New Drug Application (NDA) for ganciclovir ophthalmic gel, 0.15%, has been accepted for review by the U.S. Food and Drug Administration (FDA). Sirion Therapeutics is seeking approval for ganciclovir as a treatment for herpetic keratitis, an ocular disease caused by the herpes simplex virus. The FDA has issued an action date in late fall of...

2008-11-03 12:00:26

TAMPA, Fla., Nov. 3 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that studies of two investigational drugs in development for treatment of potentially blinding eye diseases will be presented at upcoming ophthalmology meetings: At the American Uveitis Society's annual invitational meeting (November 9, Atlanta Marriott Marquis, Atlanta), preliminary results will be presented from an anterior uveitis trial that...

2008-07-28 09:01:47

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), said that the internationally renowned Japanese ophthalmologist and corneal researcher, Kazuo Tsubota, MD, PhD, has agreed to join the Company's Scientific Advisory Board. Dr. Tsubota is currently Professor and Chairman of the Department of Ophthalmology at Keio University School of Medicine in Tokyo, Japan. "I have already had licensing discussions with Japanese pharmaceutical companies regarding EkcCide(TM)," said Dr. Tsubota, adding,...

2007-06-28 09:00:32

Bausch & Lomb today introduced its Ocuvite DF eye vitamin supplement, specifically developed for diabetics to help maintain eye health, at the American Optometric Association's (AOA) 110th Annual Congress. Diabetics face high blood sugar levels that can increase free radicals in the body. The oxidative stress associated with free radicals can in turn play a role in damaging the blood vessels of the eye's retina, a condition called diabetic retinopathy. This condition is the most...

2006-08-22 16:53:04

By Julie Steenhuysen CHICAGO (Reuters) - Bausch & Lomb Inc.'s global recall of a popular contact lens solution in May appears to have stopped the spread of a serious eye infection but U.S. scientists still do not know what caused the outbreak, according to a study released on Tuesday. Researchers at the U.S. Centers for Disease Control and Prevention found no infection within the Bausch & Lomb solution but do not believe improper lens hygiene practices by consumers alone are...

2006-08-22 16:06:45

By Julie Steenhuysen CHICAGO (Reuters) - Bausch & Lomb Inc.'s global recall of a popular contact lens solution in May appears to have stopped the spread of a serious eye infection but U.S. scientists still do not know what caused the outbreak, according to a study released on Tuesday. Researchers at the U.S. Centers for Disease Control and Prevention found no infection within the Bausch & Lomb solution but do not believe improper lens hygiene practices by consumers alone are...

2006-08-22 15:10:00

By Julie Steenhuysen CHICAGO (Reuters) - Bausch & Lomb Inc.'s global recall of a popular contact lens solution in May appears to have stopped the spread of a serious eye infection but U.S. scientists still don't know what caused the outbreak, according to a study released on Tuesday. Researchers at the U.S. Centers for Disease Control and Prevention do not believe improper lens hygiene practices alone are enough to explain the recent rash of cases of fusarium keratitis. "We feel pretty...


Latest keratitis Reference Libraries

Onchocerca volvulus
2014-01-12 00:00:00

Onchocerca volvulus is a species of roundworm that is classified within the Nematoda phylum. This species causes the disease onchocerciasis, more commonly known as river blindness. The life cycle of this species is dependent upon an intermediate host, typically the black fly, and a definitive host, which is always a human. Its lifecycle begins when a black fly ingests microfilariae from a human host by consuming blood. The microfilariae that were present in the skin of the human host now...

More Articles (1 articles) »